Heme/oncology drugs Flashcards

(97 cards)

1
Q

mech: heparin

A

cofactor for antithrombin activation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PT or PTT elevated with heparin?

A

Only PTT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

heparin side effects

A
  1. thrombocytopenia (HIT)

2. osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

benefit of low molecular weight heparins?

A

act more on factor Xa, better bioavailability and a longer half life
–no lab monitoring needed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

pathophys: hepariin induced thrombocytopenia

A

development of IgG antibodies against heparin bound to platelet factor 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Lepirudin, bivalirudin: derived from?

A

derivative of hirudin, from leeches

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mech: lepirudin, bivalirudin?

A

inhibit thrombin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

when would you use lepirudin/bivalirudin?

A

If a pt cannot use heparin because of HIT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

warfarin metabolized by

A

cytochrome P450

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

warfarin affects PT or PTT?

A

PT. affects extrinsic pathway.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

clinical use of warfarin

A

chronic anticoagulation after STEMI, DVT, prevention of stroke in Afib

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

warfarin contraindicated in

A

pregnancy. Unlike heparin, which does NOT cross the placenta

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Tox: warfarin

A

skin/tissue necrosis
drug/drug interactions
-teratogenic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

which inhibits coagulation in vitro, heparin or warfarin?

A

heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

alteplace, reteplace, tenecteplase

tPA, rPA, TNK-tPA

A

thrombolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

tPA mechanism

A

aids conversion of plasminogen to plasmin, which cleaves thrombin and fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

tPA: PT or PTT change?

A

Increases both

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

reversal of tPA overdose with

A

aminocaproic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

tPA contraindicated in

A

active bleed
history of intracranial bleed
bleeding diathesis
severe hypertension

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

aspirin effect on PT or PTT

A

none

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

aspirin decreases plasma levels of

A

TXA2 and prostaglandins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

tox: ticlopidine

A

neutropenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

clopidogrel
ticlopidine
prasugrel
ticagrelor

A

ADP receptor inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ADP receptor inhibitor: usage

A

acute coronary syndrome
coronary stenting
decreased incidence of thrombotic stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
cilostazol mechanism
phosphodiesterase III inhibitor. Increases cAMP in platelets, inhibiting aggregation --also a vasodilator
26
indications: cilostazol
intermittent claudication, prevention of stroke | angina prophylaxis
27
dipyridamole class
phosphodiesterase II inhibitor like cilostazol.
28
tox: cilostazol
nausea, headache, facial flushing, hypotension
29
eptifibatide
GpIIb/IIIa inhibitor
30
tirofiban
GpIIb/IIIa inhibitor
31
toxicity of GpIIb/IIIa inhibitors
bleeding, thrombocytopenia
32
which cancer drugs work on the M phase
vinca alkaloids | taxols
33
which cancer drugs work on the G2 phase
bleomycin and etoposide
34
which cancer drugs work on the S phase
etoposide and antimetabolites
35
Methotrexate: mechanism
decreases dTMP | decreases dNA
36
methomtrexate for which cancers?
leukemia lymphoma choriocarcinoma sarcoma
37
methotrexate use: nonneoplastic
abortion ectopic pregnancy RA psoriasis
38
tox: methotrexate
myelosuppression macrovesicular fatty change in liver mucositosis teratogen
39
tx of methotrexate myelosuppression
folinic acid | leucovorin
40
5-FU: indication
colon cancer | basal cell carcinoma, topical
41
tox: FU
myelosuppression. | photosensitivity
42
tx for FU myelosuppression?
thymidine. Note: leucovorin does NOT help! Because even if sufficient amount of N5, N10 THF, the enzyme thymidylate synthase doesn't work
43
mechanism: cytarabine
inhibition of DNA polymerase. A pyrimidine analog
44
Use: cytarabine
leukemia and lymphoma
45
tox: cytarabine
leukopenia thrombocytopenia megaloblastic anemia
46
azathioprine, 6mercaptopurine, and 6thioguanine mech
purine analog decrease purine synthesis
47
activation of azathioprine/6MP requires
HGPRT
48
tox of azathioprine
bone marrow, GI, liver
49
what drug should you NOT give with azathioprine and 6MP?
allopurinol. Because it's metabolized by xanthine oxidase!
50
mechanism: dactinomycin
intercalates DNA
51
tox: dactinomycin
myelosuppression
52
clinical use of dactinomycin
wilms' tumor ewing's sarcoma rhabdomyosarcoma CHILDHOOD tumors
53
doxo/daunorubicin mechanism
generates free radicals | --INTERCALATES into DNA, causing breaks
54
Clinical use of doxorubicin
solid tumors, leukemias, lymphomas
55
toxicity of doxo/dauno
dilated cardiomyopathy myelosuppression alopecia
56
prevention of doxo/dauno cardiotoxicity
dexrazoxane
57
Bleomycin mechanism
free radicals | -breaks DNA
58
use: bleomycin
testicular cancer | hodgkins
59
toxicity of bleomycin
pulmonary fibrosis | skin changes
60
which cancer agents are alkylating
cyclophosphamide, ifosfamide busulfan nitrosoureas
61
cyclophosphamide, ifosfamide mech
covalently X links DNA at guanine N7
62
cyclophosphamide requires activation by
liver
63
Side effects of cyclophosphamide
myelosuppression | hemorrhagic cystitis
64
how to prevent cyclophosphamide hemorrhagic cystitis
mesna, binds toxic metabolite
65
use: cyclophosphamide
solid tumors, brain cancers | leuk, lymph
66
carmustine, lomustine, semustine, stretpzocin
nitrosureas
67
carmustine and friends mechanism
bioactivation then crosses blood brain barrier
68
use: nitrosureas (carmustine)
brain tumors like GBM
69
tox of nitrosureas
CNS dizziness and ataxia
70
busulfan mechanism
alkylates DNA
71
use: busulfan
CML | --also bone marrow ablation
72
tox: busulfan
pulmonary fibrosis | hyperpigmentation
73
Mech: vincrinstine, vinblastine
Bind tubulin and block microtubule polymerization
74
vincristine tox
neurotox (areflexia, peripheral neuritis, ileus)
75
vinblastine tox
bone marrow suppression
76
paclitaxel mechanism
stabilizes polymerized microtubules in M phase. mitotic spindles can't break down-->no anaphase
77
indications of paclitaxel
ovarian/breast
78
tox of paclitaxel
myelosuppression | hypersensitivity
79
cisplatin/carboplatin tox
nephrotoxicity and acoustic nerve damage
80
prevent cisplastin nephrotoxicity with
amifostine, a free radical scavenger and chloride diuresis
81
indications of cisplatin
testicular, bladder, ovary, lung cancer
82
etoposide, teniposide mechanism:
inhibit topoisomerase II=DNA degradation
83
tox of etoposide
myelosuppression GI alopecia
84
hydroxyurea affects which phase of cell cycle
S phase | --inhibits ribonucleotide reductase
85
prednisone cancer use?
CLL | non-hodgkins. triggers apoptosis
86
tamoxifen/raloxifene mechanism
blocks estrogen binding to receptor
87
SERM indication
breast cancer and osteoporosis
88
tamoxifen tox
increased endometrial cancer and hot flashes. partial endometrial agonist
89
raloxifen tox
NO increase in endometrial carcinoma. complete antagonist
90
trastuzumab mechanism
antibody against HER2, a tyrosine kinase
91
trastuzumab tox
cardiotoxicity
92
imatinib toxicity
fluid retention
93
rituximab indications
NHL, rheumatoid arthritis
94
vemurafenib mechanism
inhibits B-Raf kinase with V600E mutation
95
use: vemurafenib
metastatic melanoma
96
bevacizumab use:
Solid tumors
97
mechanism bevacizumab
monoclonal antibody against VEGF